Drug maker to ask Health Canada to authorize COVID-19 shot for kids as young as five next week.
Pfizer is seeking approval in both Canada and the U.S. to allow use of the vaccine in kids aged five to 11.
Several media outlets report the drugmaker filed a formal request to the U.S. Food and Drug Administration today, and plans to submit a request to Health Canada in mid-October.
The FDA will meet on October 26th to discuss the issue.
Last week, Pfizer submitted data to both agencies to form a clinical trial on children in that age bracket.
The dose for younger children in the trial is about one-third the size of an adult shot.
Young Offender Arrested in Vape Store Theft
150th Birthday Celebrated at Montebello Park
City Encouraged to Go After Funding
Cost of Renewing Vows Could Rise
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved